Alembic Pharmaceuticals Limited (APLLTD) announced USFDA final approval for Oseltamivir Phosphate Oral Suspension, 6 mg/mL, expanding its generic drug portfo.
Alembic Pharmaceuticals Limited (APLLTD) receives final approval from USFDA for Tretinoin Cream USP, 0.05%, with an estimated market size of US$ 76 million.
Natco Pharma Limited (NSE: NATCO PHARM) announces FDA approval for Eribulin Mesylate Injection, a bioequivalent to Halaven®.
Alembic Pharmaceuticals Limited (APLLTD) announces USFDA final approval for its Levothyroxine Sodium Tablets, expanding its generic drug portfolio.